Why Are Clinicians Not Embracing the Results from Pivotal Clinical Trials in Severe Sepsis? A Bayesian Analysis

Andre C. Kalil, Junfeng Sun · 2008

Read Why Are Clinicians Not Embracing the Results from Pivotal Clinical Trials in Severe Sepsis? A Bayesian Analysis by Andre C. Kalil, Junfeng Sun (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002291.txt.

Description

Andre Kalil and Junfeng Sun asked why doctors have been slow to adopt five trial-proven treatments for severe sepsis, in a 2008 PLOS ONE paper. Five pivotal trials had shown lower mortality with intensive insulin therapy, activated protein C, low-tidal volume ventilation, low-dose steroids, and early goal-directed therapy. Expert guidelines recommended all five, yet uptake in practice lagged.

The authors used a Bayesian analysis, which weighs how strong each trial's evidence really is. Their reading helps explain clinician caution: some celebrated results rest on single trials with fragile statistics. The paper is a lesson in reading landmark trials with a cooler head.

Catalog record

CREATORAndre C. Kalil, Junfeng Sun
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002291

Browse the full library · About the Tower of Babel